|
|
|
0-50481
|
56-1953785
|
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
£
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
|
£
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
£
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
|
£
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13e-4(c))
|
(c) |
Exhibits
|
Exhibit
#
|
Description
|
|
3.1
|
Certificate
of Amendment of Amended and Restated Certificate of
Incorporation
|
AEOLUS PHARMACEUTICALS, INC. | ||
|
|
|
Date: March 27, 2006 | By: | /s/ Michael P. McManus |
Michael P. McManus |
||
Chief Accounting Officer, Treasurer and Secretary |
Exhibit
#
|
Description
|
|
3.1
|
Certificate
of Amendment of Amended and Restated Certificate of
Incorporation
|